Found Review

Found: a membership-first weight platform built for the mainstream

Found is one of the more recognizable names in the GLP-1 telehealth crowd, and it earns that profile by being broad rather than boutique. It runs as a personalized weight-care membership available in all 50 states, pairing a low monthly entry price with compounded semaglutide and tirzepatide. If you want a well-rounded program that treats medication as one piece of a bigger behavior-change picture — and you don't want to overthink whether the service reaches your state — Found is a sensible default. It is less the right pick for someone hunting the single cheapest vial or someone who insists on brand-name pens from day one.

How the membership-plus-medication pricing actually works

The thing to understand about Found is that you are buying a membership, and the membership is where the compounded medication lives. Found's own plans-and-pricing page states that compounded medications are included in the cost of both its insurance and cash-pay plans, so the monthly figure you see is meant to cover the program and the compounded drug together rather than billing them as two separate line items. The entry rate starts at $129 a month, which sits below the category median of $169 — that's the lever Found pulls to win mainstream shoppers.

There's an important caveat baked into that bundle. Branded GLP-1s are not part of the included price. If you and your clinician decide you want a name-brand pen instead of a compounded formulation, that medication is billed separately and the cost climbs steeply — brand-name GLP-1 therapy runs from the mid-hundreds to well over a thousand dollars a month depending on the specific drug. So the headline $129 only holds while you stay on the compounded track.

Found does not appear to run a discounted first-month teaser; it doesn't publish a separate promo rate, so treat the starting monthly price as the real number rather than waiting for an intro deal to expire.

The medications and how they're dispensed

On the cash-pay side, Found leans on compounded semaglutide and compounded tirzepatide — the same two active ingredients behind Wegovy/Ozempic and Zepbound/Mounjaro, prepared by a compounding pharmacy rather than the original manufacturer. Having both available matters: tirzepatide and semaglutide behave differently, and a provider that stocks both gives your clinician room to switch if one stalls or causes side effects.

Found can also prescribe the branded medications — Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza — and it maintains an interactive insurance map showing carrier availability by state, which is a genuinely useful tool if you're hoping to get a brand pen covered through your plan. Just remember those branded options sit outside the bundled membership price.

What genuinely sets Found apart

Found's real differentiator isn't the drug — plenty of providers compound the same molecules — it's how much non-drug program comes attached. Every plan includes full access to a licensed medical team, and the membership wraps in behavioral guidance, an AI companion for between-visit support, and a member community. Coaching and clinical contact are built in, not sold as add-ons. For people who have learned the hard way that a prescription alone doesn't change habits, that scaffolding is the reason to choose Found over a bare-bones pharmacy-style service.

• Compounded semaglutide and tirzepatide included in the membership price
• Licensed medical team access on every plan
• Behavioral coaching, an AI companion, and a member community built in
• Both insurance and cash-pay pathways, with a state-by-state coverage map
• Nationwide availability across all 50 states

Who should pick Found, and who should skip it

Choose Found if you want an all-in-one program — medication, clinician, and habit support in one membership — and you value reliability and reach over chasing the rock-bottom price. It's also a strong option if you might want to run your insurance benefits, given the coverage map and the dual insurance/cash-pay plans.

Skip it if you're a price-only shopper who wants the cheapest possible compounded vial with no membership wrapper, or if your priority is a brand-name pen — because the moment you move off compounded, the separate medication billing erases Found's pricing advantage. It's also not the best fit if you want every program detail spelled out before you sign up; Found publishes less granular information about visit cadence, dosing schedules, and refund terms than some competitors, so you'll likely need to confirm specifics with their team.

Trust, safety, and medical oversight

Found carries no FDA warning letters on file with us, and clinical oversight is a stated part of every plan via its licensed medical team — a reassuring baseline. That said, our verification confidence is tempered by two gaps: Found doesn't publicly name the accredited compounding pharmacy behind its formulations, and its public program documentation is thinner than average. On insurance plans, note that included visits may still carry copays. None of that is a red flag, but it's the kind of detail worth asking about directly before your first charge.

Bottom line

Found is a solid, mainstream choice: nationwide access, a genuinely low $129-a-month entry on compounded GLP-1s, both major molecules on the menu, and a real coaching-and-community program wrapped around the prescription. The honest trade-offs are limited public transparency and a price advantage that only holds on the compounded track. If you want a dependable, well-supported program and you're comfortable on compounded medication, Found is easy to recommend. For more on how we weigh price, access, and oversight, see our scoring methodology.